Curvebeam Ai Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.318x

Curvebeam Ai Ltd cash flow conversion efficiency. Based on the latest financial reports, Curvebeam Ai Ltd (CVB) has a cash flow conversion efficiency ratio of -0.318x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.17 Million ≈ $-7.90 Million USD) by net assets (AU$35.11 Million ≈ $24.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Curvebeam Ai Ltd (2022–2025)

Cash flow conversion efficiency of Curvebeam Ai Ltd from 2022 to 2025. This chart illustrates how Curvebeam Ai Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Curvebeam Ai Ltd share price for real-time trading data and today's change.

Curvebeam Ai Ltd Cash Flow Conversion Ratio Explained

Curvebeam Ai Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Curvebeam Ai Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Curvebeam Ai Ltd ranked by their cash flow conversion efficiency. Also see CVB company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
BetterLife Pharma Inc F:NPAU	0.030x
Elite Education Group International Ltd NASDAQ:EEIQ	-0.327x
ASN Broker Public Company Limited BK:ASN	0.027x
Eng Kah Corporation Bhd KLSE:7149	-0.023x
Prolexus Bhd KLSE:8966	-0.039x
CN Asia Corporation Bhd KLSE:7986	0.017x
DB ENERGY S.A. ZY -10 F:0CJ	-0.016x
Robogroup TA:ROBO	-0.260x

Annual Cash Flow Conversion Efficiency for Curvebeam Ai Ltd (2022–2025)

The table below shows the annual cash flow conversion efficiency of Curvebeam Ai Ltd from 2022 to 2025. Review how financially flexible is Curvebeam Ai Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$35.11 Million ≈ $24.84 Million	AU$-11.17 Million ≈ $-7.90 Million	-0.318x	+43.36%
2024-06-30	AU$38.92 Million ≈ $27.54 Million	AU$-21.86 Million ≈ $-15.47 Million	-0.562x	-224.65%
2023-06-30	AU$-48.10 Million ≈ $-34.03 Million	AU$-21.67 Million ≈ $-15.34 Million	0.451x	--
2022-06-30	AU$0.00 ≈ $0.00	AU$-7.99 Million ≈ $-5.65 Million	x	--

About Curvebeam Ai Ltd

AU:CVB Australia Medical Devices

Market Cap

$5.41 Million

AU$7.64 Million AUD

Market Cap Rank

#28339 Global

#1458 in Australia

Share Price

AU$0.02

Change (1 day)

+6.67%

52-Week Range

AU$0.02 - AU$0.09

All Time High

AU$0.50